Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol.
Sever
P S
PS
Imperial College of Medicine, NHLI Division, Department of Clinical Pharmacology, QEQM Wing, St Mary's Hospital, London W2 1NY, UK. p.sever@ic.ac.uk
Dahlöf
B
B
Poulter
N R
NR
Wedel
H
H
Beevers
G
G
Caulfield
M
M
Collins
R
R
Kjeldsen
S E
SE
McInnes
G T
GT
Mehlsen
J
J
Nieminen
M
M
O'Brien
E
E
Ostergren
J
J
D017311:Amlodipine / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use; D001581:Benzothiadiazines; D003327:Coronary Disease / Q000188:drug therapy / Q000517:prevention & control*; D004232:Diuretics; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D009203:Myocardial Infarction / Q000517:prevention & control*; D020913:Perindopril / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D017311:Amlodipine; D001262:Atenolol; D020913:Perindopril